09.06.22
NutriLeads BV has signed a commercial agreement with Royal DSM to bring premix and market-ready solutions that feature the company’s immune health ingredient BeniCaros to the U.S. supplement market. BeniCaros is a bioactive polysaccharide (fiber) derived from upcycled carrot pomace.
The partnership will enable accelerated innovation and product development of premixes and other custom solutions that support immunity via gut modulation, according to the companies. The agreement brings together BeniCaros, an ingredient shown to accelerate immune responses, and the product development expertise and market access of Royal DSM.
“We are pleased to partner with DSM to accelerate the availability of BeniCaros to U.S. consumers through innovative new premix and market-ready solutions,” said Joana Carneiro, PhD, NutriLeads CEO. “DSM’s deep expertise in every stage of product development will help BeniCaros more quickly achieve its tremendous potential.”
According to LutriLeads, BeniCaros trains the immune system to be fit year-round through a dual action that both prepares innate immune cells and also stimulates beneficial gut microorganisms to accelerate immune responses.
Peer-reviewed clinical research demonstrates that BeniCaros accelerated protective immune responses and significantly reduced the severity and duration of symptoms after a controlled challenge with a common cold virus. BeniCaros’ daily serving size of 300 mg makes it well-suited for premixes and combination products, the companies noted.
“Consumers increasingly recognize the link between immune health and gut health, as well as the importance of well-balanced microbiota to their overall health,” said Martin Dos Ramos, vice president, Human Nutrition & Care, Dietary Supplements, DSM. “BeniCaros is an attractive, science-based immune health ingredient that supports these top consumer health concerns. We see excellent potential for product innovation. This agreement further strengthens our end-to-end offerings across the entire product development cycle and supports our partnership with customers to shape and drive new markets.”
The partnership will enable accelerated innovation and product development of premixes and other custom solutions that support immunity via gut modulation, according to the companies. The agreement brings together BeniCaros, an ingredient shown to accelerate immune responses, and the product development expertise and market access of Royal DSM.
“We are pleased to partner with DSM to accelerate the availability of BeniCaros to U.S. consumers through innovative new premix and market-ready solutions,” said Joana Carneiro, PhD, NutriLeads CEO. “DSM’s deep expertise in every stage of product development will help BeniCaros more quickly achieve its tremendous potential.”
According to LutriLeads, BeniCaros trains the immune system to be fit year-round through a dual action that both prepares innate immune cells and also stimulates beneficial gut microorganisms to accelerate immune responses.
Peer-reviewed clinical research demonstrates that BeniCaros accelerated protective immune responses and significantly reduced the severity and duration of symptoms after a controlled challenge with a common cold virus. BeniCaros’ daily serving size of 300 mg makes it well-suited for premixes and combination products, the companies noted.
“Consumers increasingly recognize the link between immune health and gut health, as well as the importance of well-balanced microbiota to their overall health,” said Martin Dos Ramos, vice president, Human Nutrition & Care, Dietary Supplements, DSM. “BeniCaros is an attractive, science-based immune health ingredient that supports these top consumer health concerns. We see excellent potential for product innovation. This agreement further strengthens our end-to-end offerings across the entire product development cycle and supports our partnership with customers to shape and drive new markets.”
